EPCAM and retinoblastoma: In this study, internalization of the EpCAM antibody-conjugated AuNP-PEI and delivery of the EpCAM siRNA resulted in a significant downregulation of EpCAM gene expression and viability in retinoblastoma Y79 cells [124].